Aarti Drugs Ltd.

NSE: AARTIDRUGS  SECTOR: Pharmaceuticals & Drugs

715.35
+30.2 (4.41%)

Price Summary

Today's High

₹ 719

Today's Low

₹ 686.85

52 Week High

₹ 1025

52 Week Low

₹ 105.56

FinStar

Ownership Stable
Ownership strength is slightly missing the benchmark.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyExcellent
The company knows very well the utilization of its assets.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.

Company Essentials

Market Cap

6667.062 Cr.

Enterprise Value

7032.0288 Cr.

No. of Shares

9.32 Cr.

P/E

29.48

P/B

7.99

Face Value

₹ 10

Div. Yield

0.07%

Book Value (TTM)

₹  89.5386

CASH

3.847 Cr.

DEBT

368.8138 Cr.

Promoter Holding

61.44%

EPS (TTM)

₹  24.2639

Sales Growth

12.4234452642923%

ROE

23.7949207399829 %

ROCE

21.2876051841957 %

Profit Growth

8.29854268277019 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1w1m3m6m1Yr3Yr5Yr

* Prices are based on daily market changes.

Valuation Chart 1w1m3m6m1Yr3Yr5Yr

* The chart is based on the standalone earnings of the company.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

Sales Growth (in Cr.)

1 Year12.42%
3 Year14.51%
5 Year8.5%

Profit Growth (in Cr.)

1 Year55.49%
3 Year21.59%
5 Year11.82%

ROE%

1 Year23.79%
3 Year20.01%
5 Year20.16%

ROCE %

1 Year21.29%
3 Year18.44%
5 Year18.35%

Debt/Equity

0.593148013679849

Price to Cash Flow

33.99

Interest Cover Ratio

5.89576664801343

CFO/PAT (5 Yr. Avg.)

1.63559360923312

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2020 61.44 0
Dec 2019 61.62 0
Sep 2019 61.64 0
Jun 2019 62.25 0
Mar 2019 62.26 0
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 21.5886455211349% for the Past 3 years.
  • Company has been maintaining healthy ROE of 20.0110903951885% over the past 3 years.
  • Company’s PEG ratio is 0.513900872400818.
  • The company has a good cash flow management; CFO/PAT stands at 1.63559360923312.
  • The company has a high promoter holding of 61.44%.

 Limitations

  • The company has shown a poor revenue growth of 14.5143309695739% for the Past 3 years.

Quarterly Result (All Figures in Cr.)

PARTICULARS Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020
Net Sales 442.71 415.61 406.57 475.55 515.16
Total Expenditure 377.49 356.31 338.97 359.45 406.18
Operating Profit 65.22 59.3 67.6 116.1 108.98
Other Income 0.21 0.13 0.61 1.24 0.26
Interest 8.08 8.08 7.24 6.39 6.98
Depreciation 11.55 11.85 11.99 11.92 11.97
Exceptional Items 0 0 8.38 0 0
Profit Before Tax 45.8 39.51 57.36 99.03 90.29
Tax 15 12.75 0.8 26 20.5
Profit After Tax 30.8 26.76 56.56 73.03 69.79
Adjusted EPS (Rs) 0.33 0.29 0.61 0.78 0.75

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Net Sales 1075.5 1088.72 1140.46 1454.25 1634.92
Total Expenditure 899.74 909.74 955.32 1251.51 1386.98
Operating Profit 175.76 178.98 185.13 202.74 247.95
Other Income 0 3.53 1.17 2.51 1.06
Interest 47.34 38.05 36.3 41 35.74
Depreciation 35.58 36.69 37.8 40.39 46.67
Exceptional Items 0 0 0 3.77 8.38
Profit Before Tax 92.84 107.78 112.21 127.62 174.97
Tax 26.55 32.3 38.8 40.37 39.3
Net Profit 66.29 75.48 73.41 87.26 135.67
Adjusted EPS (Rs.) 6.84 7.91 7.78 9.25 14.56

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Equity and Liabilities
Share Capital 24.22 23.86 23.58 23.58 23.3
Total Reserves 326.1 363.11 409.59 494.99 598.49
Borrowings 175.21 187.45 186.16 195.26 176.28
Other N/C liabilities 52.1 92.53 108.18 111.73 116.63
Current liabilities 477.08 449.18 588.74 547.36 555.99
Total Liabilities 1054.7 1116.12 1316.24 1372.93 1470.7
Assets
Net Block 462.77 542.32 563.59 585.67 611.57
Capital WIP 34.04 14.13 27.99 32.37 10.96
Investments 11.12 18.42 17.24 18.92 20.38
Loans & Advances 4.74 11.76 10.77 0.97 2.42
Other N/C Assets 0 0 0 0 0
Current Assets 542.03 529.48 696.65 735 825.36
Total Assets 1054.7 1116.12 1316.24 1372.93 1470.7
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
Profit Before Tax 92.84 107.78 112.21 127.62 174.97
Adjustment 78.2 68.2 71.06 70.77 79.82
Working Capital Changes -25.75 17.93 -99.42 -22.19 -21.34
Tax Paid -20.02 -19.51 -21.92 -28.91 -37.32
Operating Cash Flow 125.27 174.41 61.93 147.3 196.15
Investing Cash Flow -87.4 -96.29 -71.09 -59.33 -29.35
Financing Cash Flow -36.79 -78.42 9.12 -86.96 -167.76
Net Cash Flow 1.07 -0.31 -0.04 1.01 -0.96

Corporate Actions

Ratings & Research Reports

Company Presentations

Company News

Aarti Drugs Stock Price Analysis and Quick Research Report. Is Aarti Drugs an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Aarti Drugs and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Its cash from the operating activity was Rs 196.1475 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Aarti Drugs has a Debt to Equity ratio of 0.593148013679849 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Aarti Drugs , the EPS growth was 57.3691769259755 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Aarti Drugs has OPM of 15.1655858811613 % which is a good sign for profitability.
     
  • ROE: Aarti Drugs have a healthy ROE of 23.7949207399829 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
Brief about Aarti Drugs

X